ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE

This literature review presents current concepts of antiplatelet therapy as an important component of secondary prevention of ischemic stroke. Based on evidence-based medicine data, characteristics of antiplatelet agents included in clinical guidelines and standards for treating patients with ischemic stroke are presented. The main principles of selection and tactics for prescribing antiplatelet drugs to patients with ischemic stroke at different stages of the disease are provided.